Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 9, 2025

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
04:50

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

183

Cholangiocarcinoma.

Jon M Harrison1, Brendan C Visser1

  • 1Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Shanford Univeristy Hospital, 300 Pasteur Drive, H3680, Stanford, CA 94305-5655, USA.

The Surgical Clinics of North America
|October 24, 2024
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

'UNMIXING' Mixed-Type Intraductal Papillary Mucinous Neoplasms: Rethinking Malignancy Risk Beyond Radiological Appearance.

Annals of surgery·2026
Same author

Robotic converts: does everyone see the light?

Gland surgery·2026
Same author

NFAT mediates pro-tumorigenic inflammation in cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.

Cell reports·2026
Same author

The São Paulo International Consensus on Minimally Invasive Pancreatic Surgery for Cancer.

HPB : the official journal of the International Hepato Pancreato Biliary Association·2025
Same author

Disruption of fibroblast MYD88 signaling promotes antitumor immunity in pancreatic ductal adenocarcinoma.

Cell reports·2025
Same author

Fowl territory: A novel visual cue for staying in bounds during anatomic liver resection.

Surgery·2025
Same journal

Social Determinants of Health, Health Disparities, and Surgical Equity.

The Surgical clinics of North America·2026
Same journal

Beyond the Scalpel's Reach.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Society.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Hospitals.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions for Providers.

The Surgical clinics of North America·2026
Same journal

Stepwise Solutions-Patients Social Determinants of Health, Health Disparities, and Surgical Equity.

The Surgical clinics of North America·2026
See all related articles

Surgical management of intrahepatic cholangiocarcinoma depends on tumor location and proximity to vital structures. Treatment strategies, including liver resection and augmentation, are tailored to tumor site and resectability, with adjuvant or neoadjuvant therapies for advanced cases.

Area of Science:

  • Hepatobiliary Surgery
  • Surgical Oncology
  • Gastroenterology

Background:

  • Intrahepatic cholangiocarcinoma (ICC) management requires precise understanding of tumor location relative to critical vasculobiliary structures.
  • Surgical resection is a primary treatment modality, necessitating careful preoperative planning.

Purpose of the Study:

  • To outline current surgical strategies for intrahepatic cholangiocarcinoma based on tumor location.
  • To emphasize the importance of volumetric assessment and preoperative liver augmentation.
  • To discuss the role of adjuvant and neoadjuvant therapies in managing resectable and advanced ICC.

Main Methods:

  • Review of surgical approaches for ICC based on anatomical location (mid-common bile duct, distal common bile duct, perihilar).
Keywords:
Biliary tract tumorsDistal common bile duct cancerExtrahepatic cholangiocarcinomaIntrahepatic cholangiocarcinomaKlatskin tumor

More Related Videos

Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection
07:22

Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection

Published on: April 11, 2025

97
Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma
09:19

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma

Published on: July 14, 2022

3.3K

Related Experiment Videos

Last Updated: Jun 9, 2025

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
04:50

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

183
Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection
07:22

Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection

Published on: April 11, 2025

97
Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma
09:19

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma

Published on: July 14, 2022

3.3K
  • Emphasis on intraoperative frozen section analysis for guiding surgical decisions.
  • Inclusion of volumetric assessment for remnant liver evaluation and planning for liver augmentation.
  • Discussion of adjuvant and neoadjuvant systemic therapy protocols.

    • Main Results:

    • Mid-common bile duct tumors may necessitate hemihepatectomy or pancreatoduodenectomy.
    • Distal common bile duct tumors are typically treated with pancreatoduodenectomy.
    • Perihilar tumors often require right trisegmentectomy with bilioenteric reconstruction for negative margins.
    • Preoperative liver augmentation strategies are crucial for select cases.
    • Adjuvant therapy is recommended, with increasing use of neoadjuvant treatment for borderline resectable or advanced ICC.

    Conclusions:

    • Tailored surgical resection, guided by tumor location and intraoperative findings, is essential for intrahepatic cholangiocarcinoma.
    • Volumetric assessment and liver augmentation are critical components of preoperative planning.
    • Systemic therapies, both adjuvant and neoadjuvant, play a significant role in optimizing outcomes for ICC patients.